Skip to content

Exercise Prehabilitation for Patients With NSCLC Before Surgery

Effect of a Home-based, Supervised Prehabilitation With Wearable Technology for Patients With Non-small Cell Lung Cancer Before Lung Resection: a Single-arm, Prospective Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05608759
Enrollment
30
Registered
2022-11-08
Start date
2022-11-01
Completion date
2025-12-28
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiorespiratory Fitness, Non Small Cell Lung Cancer, Prehabilitation, Surgery

Keywords

Prehabilitation, Cardiorespiratory fitness, Non-small cell lung cancer, Exercise, Wearable technology, Surgery

Brief summary

To explore the safety and compliance of a wearable telemedicine device that can receive basic vital signs in real time, and its active supervision mode with real-time adjustment of exercise prescription for preoperative prehabilitation exercises in patients at home; and to evaluate the effectiveness of preoperative prehabilitation exercises in a telemedicine active supervision mode in patients undergoing thoracoscopic lung tumour resection, taking into account the patient's cardiopulmonary exercise test, postoperative complications and quality of life scores.

Interventions

BEHAVIORALMultimodal prehabilitation

4 weeks of an supervised, pre-operative exercise prescription augmented by a wearable fitness device.

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Capacity to give informed consent. 2. Are able to tolerate surgery (i.e., segmentectomy, lobectomy) as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiopulmonary exercise testing. 3. Patients who can use a smartphone application. 4. Patients who are diagnosed of stage I or II Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation. 5. Patients who can perform an exercise program for at least 4 weeks from the first visit to the preoperative clinic to elective surgery.

Exclusion criteria

1. Known contraindication for cardiopulmonary exercise testing. 2. Patients who have a major medical or psychiatric disorder that is expected to affect exercise. 3. Pregnancy or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
Study feasibilityBaseline, 4 weeks after prehabilitation exerciseAssessed by the following indicators: study participation rate, screening and enrollment rates, intervention completion rate, number of completed exercise days, wearable-device wearing days and wearing rate, analyzable activity days, paper-log completion, app-based electronic-log completion, alert generation and closure, intervention discontinuation, adverse events, and serious adverse events

Secondary

MeasureTime frameDescription
Pre-post changes in cardiopulmonary exercise testingBaseline, 4 weeks of prehabilitation exercisePeak oxygen uptake, peak workload, anaerobic-threshold measures
Forced expiratory volume in 1 s(FEV1)Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgeryForced expiratory volume in 1 s (FEV1) of pulmonary function will be measured in liters
Forced vital capacity (FVC)Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgeryForced vital capacity (FVC) of pulmonary function will be measured in liters.
Change in quality of lifeBaseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgeryas assessed by the EORTC QLQ C30 questionnaire
Post-operative complications30-days after surgery (T4)Classified using the Clavien Dindo Classification
Moderate to vigorous physical activityBaseline, 4 weeks of prehabilitation exerciseDaily total minutes of moderate to vigorous physical activity (MVPA)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026